pyruvic acid has been researched along with 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altherr, J; Brinkmann, A; Brückner, UB; Georgieff, M; Jauch, KW; Matejovic, M; Radermacher, P; Träger, K; Vlatten, A; Vogt, J; Wachter, U; Zülke, C | 1 |
1 other study(ies) available for pyruvic acid and 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid
| Article | Year |
|---|---|
Hepatic oxygen exchange and energy metabolism in hyperdynamic porcine endotoxemia: effects of the combined thromboxane receptor antagonist and synthase inhibitor DTTX30.
Topics: Animals; Blood Gas Analysis; Blood Glucose; Chlorobenzenes; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxemia; Energy Metabolism; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Fluid Therapy; Hemodynamics; Hemoglobins; Lactates; Liver Circulation; Oxygen Consumption; Prospective Studies; Pyridines; Pyruvic Acid; Random Allocation; Statistics, Nonparametric; Swine | 2001 |